MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Valeria Runfola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy. Hauptthemen laut MEDLINE: Homeodomain Proteins, Muscular Dystrophy, Facioscapulohumeral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Te…
- ProMeFa, Proteomics and Metabolomics Facility, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy. Electronic address: gabellini.davide@hsr.it.
Förderung
- NCI NIH HHS
- Ministero della Salute
- Associazione Italiana per la Ricerca sul Cancro
- National Institutes of Health
- Fondazione Italiana per la Ricerca sul Cancro Airc
- National Cancer Institute
- University of Rochester
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Runfola, V., Giambruno, R., Caronni, C., Pannese, M., Andolfo, A., & Gabellini, D. (2023). MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113120
Vancouver
Runfola V, Giambruno R, Caronni C, Pannese M, Andolfo A, Gabellini D. MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113120
BibTeX
@article{Runfola2023,
author = {Runfola, Valeria and Giambruno, Roberto and Caronni, Claudia and Pannese, Maria and Andolfo, Annapaola and Gabellini, Davide},
title = {MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113120}
}
EUVIMED